# Phase Ib/IIa Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Advanced Lung Cancer

> **NCT03751592** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd** · enrollment: 144 (estimated)

## Conditions studied

- Advanced Lung Cancer

## Interventions

- **DRUG:** Chlorogenic acid

## Key facts

- **NCT ID:** NCT03751592
- **Lead sponsor:** Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07-17
- **Primary completion:** 2020-10-30
- **Final completion:** 2021-04-30
- **Target enrollment:** 144 (ESTIMATED)
- **Last updated:** 2018-11-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03751592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03751592, "Phase Ib/IIa Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Advanced Lung Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03751592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*